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Acute inactivation of the replicative
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DNA replication fork progression can be disrupted at difficult to replicate loci in the human genome, which has the
potential to challenge chromosome integrity. This replication fork disruption can lead to the dissociation of the
replisome and the formation of DNA damage. To model the events stemming from replisome dissociation during
DNA replication perturbation, we used a degron-based system for inducible proteolysis of a subunit of the replicative
helicase. We show that MCM2-depleted cells activate a DNA damage response pathway and generate replication-
associated DNA double-strand breaks (DSBs). Remarkably, these cells maintain someDNA synthesis in the absence
of MCM2, and this requires the MCM8–9 complex, a paralog of the MCM2–7 replicative helicase. We show that
MCM8–9 functions in a homologous recombination-based pathway downstream from RAD51, which is promoted
by DSB induction. This RAD51/MCM8–9 axis is distinct from the recently described RAD52-dependent DNA
synthesis pathway that operates in early mitosis at common fragile sites. We propose that stalled replication forks
can be restarted in S phase via homologous recombination using MCM8–9 as an alternative replicative helicase.
[Keywords: DNA replication; homologous recombination; fork restart; MCM proteins; genome maintenance;
conditional degron]
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The replication of genomic DNA is essential for cell pro-
liferation and propagation of genetic information to the
next generation. Although DNA replication occurs with
remarkable fidelity, many of the genomic alterations
found in proliferating cells seem to arise from sites of per-
turbed DNA replication forks (Durkin and Glover 2007;
Aguilera and Gomez-Gonzalez 2008). In human cells, rep-
lication forks can travel over many kilobases of template
DNA and must overcome any roadblock or template ab-
normality encountered along the way. It is known that
progression of the replication forks can be impeded at cer-
tain difficult to replicate genomic regions because of the
presence of DNA secondary structures or adducts or
because the replication machinery (replisome) collides
with a transcribing RNA polymerase complex (Mirkin
and Mirkin 2007; Zeman and Cimprich 2014). To avoid
underreplication leading to genomic instability, cells
must possess mechanisms to deal with the consequences
of fork stalling and replisome disruption/disassembly.
In eukaryotic cells, DNA replication is initiated atmul-
tiple origins, which then generate bidirectional replica-
tion fork movement (Masai et al. 2010). In addition to
origins that fire in each S phase, there are many dormant
origins that are used only when cells are exposed to repli-
cation stress (Blow et al. 2011). The combination of multi-
ple replication forks operating simultaneously and
dormant origins creates an efficient fail-safe system to
guard against permanent fork arrest because arrested forks
can be rescued by a new converging fork (Supplemental
Fig. S1A). This fork convergence plays a critical role in
the maintenance of genomic integrity, as evidenced by
the finding that cells with a reduced number of replication
origins are susceptible to replication stress (Woodward
et al. 2006; Ge et al. 2007; Ibarra et al. 2008). Interestingly,
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a recent report showed that human cells experience at
least one replicon failure per S phase, where two forks
are irreversibly arrested without there being an interven-
ing origin to rescue them (Moreno et al. 2016). This fea-
ture of S phase is particularly pertinent to regions of the
genome that are origin-poor, meaning that some forks
must travel over a considerable distance without break-
down. Therefore, cells must have backup systems to
deal with situations in which two or more forks are irre-
versibly stalled; otherwise, the completion of DNA repli-
cation would be compromised.
In prokaryotes, fork restart at nonorigin sites plays a
crucial role in the protection against irreversible fork
stalling. This is particularly required in these organisms
because only a single genomic origin generates a pair of
forks that replicate the entire genome before converging
at a defined termination region. The main fork restart
pathway is dependent on the homologous recombination
(HR) machinery and is initiated at a DNA double-strand
break (DSB) at the stalled fork (Cox et al. 2000; Michel
et al. 2004). For example, replication forks in Escherichia
coli can be stalled by inactivation of the replicative DnaB
helicase (Michel et al. 1997). This generates a one-ended
DSB at the stalled fork that triggers RecBCD- and
RuvABC-dependent recombination between sister chro-
matids (Seigneur et al. 2000). Following RecA-mediated
displacement loop (D-loop) formation and the action of
the PriA–PriB–DnaT “primosome” complex, DnaB is re-
loaded for reassembly of the replisome (Seigneur et al.
1998; Heller and Marians 2006). Thus, E. coli has an effi-
cient system for reassembly of the replisome via HR trig-
gered by a one-ended DSB.
In eukaryotes, the form of HR repair used to deal with
one-ended DSBs is known as break-induced replication
(BIR) and plays an important role in both telomere main-
tenance and replication fork restart (McEachern and
Haber 2006; Llorente et al. 2008; Verma and Greenberg
2016). BIR has been characterized in budding yeast
through the analysis of interchromosomal HR induced
by a one-ended DSB (Morrow et al. 1997; Bosco and Haber
1998). DNA synthesis during BIR is carried out by DNA
polymerase δ (Pol δ), which is coupled to Pif1 helicase-de-
pendent migration of a DNAD-loop structure (Saini et al.
2013; Wilson et al. 2013). The noncatalytic Pol32 subunit
of Pol δ is essential for BIR but not bulk DNA replication
(Lydeard et al. 2007). In mammalian cells, BIR is poorly
characterized, partly because of a lack of defined assays.
However, it has been shown that the POLD3 subunit
(Pol32 homolog) of Pol δ is also required for BIR and alter-
native telomere maintenance in human cells (Costantino
et al. 2014; Dilley et al. 2016). However, in contrast to
yeast, mammalian POLD3 is essential for cell viability
(Murga et al. 2016). Importantly, the mechanism of BIR
in mammalian cells is still unclear, and it remains to be
confirmed that it plays a key role in rescuing irreversibly
stalled replication forks.
Replication forks in eukaryotes are driven by the hex-
americ MCM2–7 helicase, which forms the so-called
CMG replicative holohelicase along with CDC45 and
the GINS complex (Ilves et al. 2010). MCM2–7 activity
is tightly controlled during the cell cycle (Blow and Dutta
2005; Masai et al. 2010). The loading of MCM2–7 at ori-
gins is temporally separated from helicase activation,
with the former occurring in late M and G1 phases, and
the latter occurring only in S phase. Importantly, the load-
ing of additionalMCM2–7 is suppressed in S phase, ensur-
ing that DNA replication takes place only once per cell
cycle. This implies that, unlike in E. coli, the replisome
cannot be reassembled at a stalled fork by the reloading
of the MCM2–7 helicase.
Most eukaryotic species, with the exception of yeasts
and nematodes, have additional MCM family proteins,
known asMCM8 andMCM9 (Liu et al. 2009).We and oth-
ers reported that MCM8 and MCM9 form a distinct com-
plex that is involved in HR repair (Lutzmann et al. 2012;
Nishimura et al. 2012; Park et al. 2013). MCM9 was also
shown recently to interact with mismatch repair (MMR)
proteins and work with MCM8 as a helicase during
MMR (Traver et al. 2015). MCM8 andMCM9 are both re-
quired for gametogenesis and tumor suppression in mice
(Hartford et al. 2011; Lutzmann et al. 2012), and muta-
tions in the humanMCM8 orMCM9 genes are associated
with premature onset of menopause (He et al. 2009;
Wood-Trageser et al. 2014). Many lines of evidence point
to a role for the MCM8–9 complex as a helicase in DNA
repair, particularly in HR repair. However, there are con-
flicting views as to whether MCM8–9 is required for an
early process (e.g., DNA end resection) or a later process
in HR (Lutzmann et al. 2012; Nishimura et al. 2012; Lee
et al. 2015).
In order to define the processes required for rescue of
stalled forks in human cells and the possible role of
MCM8–9 in these processes, we generated a human cell
line in which the MCM2–7 helicase could be inactivated
in a controlled manner. For this purpose, we used auxin-
inducible degron (AID) technology, whereby a degron-
tagged protein can be rapidly degraded by adding the plant
hormone auxin (Nishimura et al. 2009; Natsume et al.
2016). This approach was adopted in order to create a sit-
uation in which the rescue of stalled forks by fork conver-
gence is not possible (Supplemental Fig. S1B). We
demonstrate that, in response to MCM2 degradation,
stalled forks are converted to DSBs that are rescued in a
RAD51-dependent manner. Crucially, this rescue re-
quires MCM8–9 to promote new DNA synthesis. Al-
though this reaction is superficially similar to the
recently described mitotic DNA synthesis (MiDAS) at
fragile sites (Minocherhomji et al. 2015; Bhowmick et al.
2016), we show that MCM8–9-dependent DNA synthesis
is distinct from MiDAS. We propose that MCM8–9 is re-
quired for HR-mediated fork restart and acts as an alterna-
tive replicative helicase to promote DNA synthesis.
Results
Construction of an MCM2 degron cell line for artificial
fork stalling
To characterize howhuman cells deal with stalled replica-
tion forks, we took inspiration from studies in prokaryotes
MCM8–9 promotes DNA synthesis after fork stalling
GENES & DEVELOPMENT 817
 Cold Spring Harbor Laboratory Press on June 26, 2017 - Published by genesdev.cshlp.orgDownloaded from 
in which the replicative DnaB helicase had been con-
ditionally inactivated using a temperature-sensitive
mutation of DnaB (Michel et al. 1997; Seigneur et al.
1998, 2000). In our case, we aimed to induce the rapid deg-
radation of MCM2, a component of the replicative
MCM2–7 helicase, by taking advantage of the AID tech-
nology (Fig. 1A; Nishimura et al. 2009; Natsume et al.
2016). To achieve this, we tagged both alleles of the
MCM2 gene with mini-AID (mAID) using CRISPR–Cas9
in theHCT116 human colorectal cancer line (Fig. 1B; Sup-
plemental S2A,B; Cong et al. 2013; Mali et al. 2013). Sub-
sequently, we introduced an AFB2 gene (derived from
Arabidopsis thaliana), which encodes a paralog of TIR1
(Supplemental Fig. S2C; Havens et al. 2012). In the resul-
tant cells, the MCM2 fusion protein (MCM2-mAID) was
degraded efficiently within 4 h of the addition of auxin
(Fig. 1C), leading to an accumulation of cells in S phase,
as expected (Supplemental Fig. S2D). To analyze this
more systematically, we synchronized cells in the G1
phase using lovastatin and then treated them with or
without auxin before releasing them into S phase (Fig.
1D,E; Javanmoghadam-Kamrani and Keyomarsi 2008). In
control cells not exposed to auxin, DNA replication was
generally completed within 19 h of release from G1 (Fig.
1E; control). In sharp contrast, a profound defect in DNA
replication was observed in cells treated with auxin (Fig.
1E, +auxin). Importantly, this clear S-phase defect could
not be seen using siRNA-mediated depletion methods
because of the presence of residual MCM2 protein (Sup-
plemental Fig. S2E,F).
Fork stalling by induced proteolysis of MCM2 during
S phase
In order to induce fork stalling only after the cells had ini-
tiated S phase, we synchronized theMCM2-mAID cells in
G1 phase as in Figure 1E but then only added auxin 13 h
after release, when most of the cells were in early S phase
(Fig. 2A,B). In control cells not exposed to auxin, DNA
replication was generally completed by the 19-h time
Figure 1. Construction ofMCM2-mAID cells for ar-
tificial fork stalling. (A) A schematic representation of
auxin-mediated proteolysis ofMCM2-mAID. An aux-
in-dependent F-box protein, AFB2 of A. thaliana
(AtAFB2), forms an E3 ubiquitin ligase with the en-
dogenous SCF components. In the presence of auxin,
MCM2-mAID is targeted by AtAFB2 for polyubiqui-
tylation and subsequent destruction by the protea-
some. (B) Evidence that clones 1 and 2 express the
MCM2-mAID protein. (C ) Time course of proteolysis
of MCM2-mAID. Asynchronously growing MCM2-
mAID cells were treated with auxin (indole-3-acetic
acid [IAA]) before harvesting at the indicated time
points. Ponceau staining shows a loading control.
(D,E) MCM2-mAID cells were arrested in G1 phase
and released into S phase after MCM2-mAID deple-
tion. In control cells, DMSO replaced auxin.
MCM2-mAID proteins were detected by immuno-
blotting using the anti-mAID antibody (D), and
DNA content was measured by flow cytometry (E).
Natsume et al.
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point, and the cells then progressed through to mitosis
(Fig. 2B, control). In contrast, the auxin-treated cells failed
to carry out bulk DNA replication and eventually lost
viability (Fig. 2B, +auxin; data not shown). The MCM2-
mAID protein was undetectable by 2 h after auxin addi-
tion, suggesting that most replication forks would be in-
activated at that point or soon afterward (Fig. 2A,
+auxin 15 h). We also confirmed that the chromatin-
bound fraction of MCM2-mAID, which is associated
with forks and origins, was efficiently degraded (Supple-
mental Fig. S3A). Intriguingly, we noted that the peak of
DNA content drifted toward a 4C DNA content between
the 15- and 21-h time points (Fig. 2B, +auxin). More de-
tailed flow cytometric analysis of cells containing a
more than 2C DNA content showed that the F1 and F2
populations decreased, while the F3 and F4 populations
increased between 15 and 21 h (Fig. 2C). This alternative
DNA synthesis that occurs without the MCM2–7 heli-
case is addressed below.
Because AID technology functions at the protein level,
we took advantage of the ability to rapidly replenish the
MCM2-depleted cells by removal of auxin from the medi-
um. For this, we induced the rapid degradation of MCM2-
mAID from 13 to 17 h after release from G1 phase, when
the cells were in early S phase, and then removed auxin to
allow MCM2-mAID re-expression (Supplemental Fig.
S3B,C). Re-expression of MCM2-mAID was detectable 2
h after auxin removal (Supplemental Fig. S3B; 19 h). How-
ever, this failed to rescue the defective replication due to
MCM2-mAID depletion (Supplemental Fig. S3C; left),
consistent with the concept that the replication licensing
system in eukaryotes prevents the replicative helicase
from being reloaded to chromosomes in S phase (Blow
and Dutta 2005). This is in contrast to the system operat-
ing in bacteria for reloading of the DnaB helicase (Marians
2000).
DNA DSBs are induced following fork stalling
Stalled replication forks can be converted into DSBs
(Petermann et al. 2010). We analyzed whether DSBs
were formed after MCM2-mAID depletion. For this, we
initially looked at the 53BP1 protein, which forms nuclear
foci upon DSB formation (Fig. 3A; Schultz et al. 2000; An-
derson et al. 2001; Rappold et al. 2001). We observed that
the auxin-treated cells accumulated 53BP1 foci in a man-
ner similar to control cells treated with bleomycin, a
known DSB-generating agent (Fig. 3B). To detect DSBs
directly in the genomic DNA, we performed pulsed-field
gel electrophoresis (PFGE) (Ray Chaudhuri et al. 2012).
This revealed that DSBs started to accumulate 4 h after
the cells were treated with auxin (Fig. 3C, 17 h). We
then analyzed the localization of RAD51 and γH2AX,
which form nuclear foci at the sites of damaged DNA
(Fig. 4A). We observed a significant enrichment of
RAD51 and γH2AX foci in the MCM2-mAID-depleted
cells (Fig. 4A, +auxin), indicating that the cells were accu-
mulatingDNAdamage. Consistentwith this, we detected
activation of the CHK1 kinase in cells treated with auxin
(Supplemental Fig. S4A). Taken together, these results in-
dicate that fork stalling induced by degradation ofMCM2-
mAID generates DNA DSBs.
The presence of γH2AX and 53BP1 nuclear foci after
MCM2-mAID depletion is indicative of replication-asso-
ciated DSBs (Figs. 3A,B, 4A). However, we were intrigued
by the colocalization of RAD51 with these DSBs,
Figure 2. MCM2-mAID degradation in
synchronized S-phase cells. (A,B) MCM2-
mAID cells were arrested in G1 phase and
then released into S phase. When most of
the released cells were in early S phase (13
h), auxin was added to induce degradation
of MCM2-mAID before taking samples at
the indicated time points. In control cells,
DMSO replaced auxin. MCM2-mAID pro-
teins were detected by immunoblotting us-
ing the anti-mAID antibody (A), and DNA
content was measured by flow cytometry
(B). (C ) The auxin-treated cells in early to
late S phasewere divided into four arbitrary
fractions (F1, F2, F3, and F4). The frequen-
cies of each fraction are indicated.
MCM8–9 promotes DNA synthesis after fork stalling
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suggestive of the activation of some form of HR at the
stalled forks. We therefore analyzed whether the
MCM8–9 complexmight be required for RAD51 focus for-
mation. To this end, we disrupted theMCM9 gene in the
MCM2-mAID background (Supplemental Fig. S4B–D).
The MCM9 knockout (MCM9-KO) cells did not show a
significant growth defect under normal growth condi-
tions, in line with our previous observation that MCM9
loss is not detrimental to the growth of chicken DT40
cells (Supplemental Fig. S4E; Nishimura et al. 2012).
Moreover, consistent with the observation that MCM8
andMCM9 function together in a complex, the formation
of DNA damage-inducedMCM8 foci was absent from the
MCM9-KO cells (Supplemental Fig. S4F; Lutzmann et al.
2012; Park et al. 2013). We then analyzed RAD51 focus
formation in the MCM9-KO cells (Fig. 4B). We observed
that three independent clones ofMCM9-KO cells formed
RAD51 foci similarily to wild-type cells (MCM9-WT), in-
dicating that MCM9 is not essential for RAD51 loading.
Conversely, we obtained evidence that RAD51 is required
for the loading of MCM8–9. In cells treated with the
RAD51 inhibitor RI-1 (RAD51i) (Budke et al. 2012), we ob-
served that MCM8 focus formation was significantly re-
duced (Fig. 4C).
Figure 3. DSBs are generated following fork stalling. (A) 53BP1
focus formation following fork stalling induced by MCM2-
mAID proteolysis. The MCM2-mAID cells were synchronized
as in Figure 2 and were treated with auxin or bleomycin. At the
17-h time point, the cells were fixed and stained with an anti-
53BP1 antibody. Bars, 10 µm. (B) Quantification of the number
of 53BP1 foci. (C ) PFGE was used to examine accumulation of
DNA breaks after fork stalling. TheMCM2-mAID cells were syn-
chronized and treated as in Figure 2. At the indicated time points,
genomic DNA from 2 × 105 cells was examined by PFGE. While
intact genomicDNA remains inwells, DNA fragments generated
byDSBsmigrate into the gel. The level of DNAbreaks (DNA frag-
ments thatmigrate into the gel) is shown below. The level of frag-
mented DNA at time 13 h is denoted as 1.0.
Figure 4. Fork stalling induces a DNA damage response. (A)
DNA damage focus formation after MCM2-mAID degradation.
TheMCM2-mAID cells were synchronized and treated with aux-
in as in Figure 2. The cells were fixed at the 19-h time point and
stained with the anti-γ-H2AX and anti-RAD51 antibodies. Bars,
10 µm. (B) MCM9 is not required for RAD51 focus formation.
The MCM2-mAID cells in MCM9 wild-type (MCM9-WT) or
knockout (MCM9-KO) backgrounds were treated with auxin for
8 h, and the number of RAD51 foci was quantified following
immunostaining. (C ) MCM8 focus formation upon MCM2-
mAID degradation requires RAD51. TheMCM2-mAID cells syn-
chronized in early S phase were treated with auxin, a RAD51 in-
hibitor (RAD51i), or both together for 4 h. The number of MCM8
foci was quantified following immunostaining.
Natsume et al.
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MCM8–9 promotes DNA synthesis as a backup
of DNA replication
As noted in Figure 2B, we observed that DNA synthesis
continued to some extent for several hours after degrada-
tion of MCM2-mAID. Although this effect might reflect
incomplete MCM2-mAID degradation, we considered
the possibility that removal of this core component of
the replisome might activate an alternative mechanism
of DNA synthesis. We therefore investigated whether
MCM8–9might contribute to thisMCM2–7-independent
DNA synthesis. For this, we synchronizedMCM9-WT and
MCM9-KO cells in G1 and then released them into S
phase as in Figure 2. In early S phase, auxin was added
to induce MCM2-mAID depletion, and then time course
samples were taken (Fig. 5A; Supplemental Fig. S5A).
TheMCM9-WT andMCM9-KO cells showed very similar
replication profiles in the absence of auxin, indicating that
MCM9 is dispensable for normal bulk DNA replication
(Fig. 5A, control). In contrast, in the auxin-treated cells
in which MCM2-mAID was degraded (Supplemental Fig.
S5A, +auxin), theMCM9-KO cells showed a reduced level
of DNA synthesis compared with theMCM9-WT cells be-
tween the 17- and 21-h time points (Fig. 5A, +auxin). This
result was confirmed by analysis of the percentage of
MCM9-KO cells present in the late stages of S phase (F3
and F4) (Supplemental Fig. S5B,C) and was also observed
in an independent MCM9-KO clone (data not shown).
To quantify this DNA synthesis defect in the MCM9-
KO cells, we used bromodeoxyuridine (BrdU) to label na-
scent DNA 4 h after auxin addition. The population of
cells labeled with BrdU was reduced in the MCM9-KO
cells compared with theMCM9-WT cells (Fig. 5B, dotted
circle).
To directly quantify ongoing DNA synthesis, we ex-
posed cells sequentially to two thymidine analogs, iodo-
deoxyuridine (IdU) and chlorodeoxyuridine (CldU), and
then performed immunodetection of the incorporated
Figure 5. MCM8–9 promotes DNA synthesis after
fork stalling. (A) MCM9-WT and MCM9-KO deriva-
tives of the MCM2-mAID cells (shown with black
and red lines, respectively) were synchronized and
treated as in Figure 2. DNA content was then mea-
sured using flow cytometry after either DMSO (left)
or auxin (right) treatment. (B) Incorporation of BrdU
after fork stallingwas examined using flow cytometry
in the MCM9-WT and MCM9-KO backgrounds. (C )
DNA synthesis after fork stallingwas examined using
isolated DNA fibers. TheMCM9-WT andMCM9-KO
derivatives of the MCM2-mAID cells were synchro-
nized and treated as in Figure 2. At the 21-h time
point, the cells were labeled with iododeoxyuridine
(IdU) followed by chlorodeoxyuridine (CldU) labeling.
The percentage of DNA fibers labeled with both IdU
and CldU was compared with those that contained
IdU only. n = 229 IdU; n = 352 CldU. (D) CldU tract
length was quantified in the wild-type (normal fork)
and MCM2-mAID cells with MCM9-WT. (E) Cells
with a reduced amount of MCM2–7 are more reliant
on MCM8–9 for their survival. MCM9-WT and
MCM9-KO derivatives of the MCM2-mAID cells
(shown in black and red lines, respectively) were al-
lowed to form colonies in the presence of various dos-
es of auxin. The colony number was counted after
crystal violet staining. The survival rate in the ab-
sence of auxin was defined as 100%.
MCM8–9 promotes DNA synthesis after fork stalling
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IdU and CldU on stretched DNA fibers (Fig. 5C). This re-
vealed that the proportion of DNA fibers labeled with
both IdU and CIdU was reduced in the MCM9-KO cells
(Fisher’s exact test, P = 0.0023). However, we still ob-
served that ∼20% of the DNA fibers incorporated both
IdU and CldU in the MCM9-KO cells. This suggests ei-
ther that there is an MCM8–9-independent mechanism
of DNA synthesis in the absence of MCM2-mAID or
that degradation of MCM2-mAID was incomplete. We
then analyzed the fork speed by measuring the length
of CldU tracts (Fig. 5D). The fork speed after MCM2-
mAID depletion was significantly slower than that
of normal forks. This result supports the notion that
MCM2-mAID depletion was efficient and that alter-
native DNA synthesis with MCM9 is qualitatively dif-
ferent from normal DNA synthesis. To define the
location of DNA synthesis in the nucleus, we degraded
MCM2-mAID using 4 h of auxin treatment and then la-
beled the MCM9-WT and MCM9-KO cells with ethynyl-
deoxyuridine (EdU) for 30 min. We observed that 17% of
the large γH2AX foci colocalized with EdU foci (Supple-
mental Fig. S6A,B). However, colocalization of EdU
and γH2AX foci was significantly reduced in the
MCM9-KO cells (Supplemental Fig. S6B). Taken togeth-
er, these results are consistent with the hypothesis that
MCM8–9 contributes significantly to DNA synthesis af-
ter forks have been stalled due to a lack of the MCM2–7
complex.
It has been shown that a reduction in MCM2–7 expres-
sion causes spontaneous fork stalling by an extension in
the size of replicons (Moreno et al. 2016). If, as we propose,
MCM8–9 functions as a backup replicative helicase, the
MCM2–7-depleted cells should have an increased reliance
on MCM8–9. To test this hypothesis, we treated the
MCM9-WT and MCM9-KO cells with various doses of
auxin to reduce, but not eliminate, the cellular level of
MCM2-mAID. We observed that the MCM9-WT cells
were more resistant to a reduction in the level of
MCM2-mAID than theMCM9-KO cells (Fig. 5E), support-
ing the hypothesis that MCM8–9 functions as a backup
replicative helicase.
MCM8–9 promotes DNA synthesis during
DSB-induced HR
Considering thatMCM8–9 plays a role in HR repair (Lutz-
mann et al. 2012; Nishimura et al. 2012; Park et al. 2013),
we investigated whether DNA synthesis occurring during
DSB-induced HR requires MCM8–9. For this, we used an
established HR reporter system in chicken DT40 cells, in
which a copy of an SCneo substrate is stably introduced at
the ovalbumin locus (Nishimura et al. 2012). These cells
can repair the neomycin (Neo) resistance gene by HR
upon expression of I-SceI, an endonuclease that generates
a DSB in S2neo (Fig. 6A). If repaired by HR, two outcomes
are possible, depending on whether short-tract gene
Figure 6. MCM8–9 promotes DNA synthesis in
DSB-induced HR. (A) Schematic illustration showing
the generation of STGC and LTGC from the SCneo
substrate integrated at the ovalbumin locus in the
chicken DT40 genome. The expressed I-SceI endonu-
clease cleaves the I-SceI site in S2neo and induces HR
repair between sister chromatids. STGC is generated
by copying 0.3–0.4 kb from 3′ neo, while LTGC is pro-
duced by a extensive DNA synthesis (>3.3 kb) from 3′
neo. (B) After I-SceI expression in wild-type, MCM8-
KO, and MCM9-KO DT40 cells, the recombination
frequency was calculated by counting G418-resistant
colonies. Error bars indicate standard deviation. n = 3.
(C ) Southern blotting using a probe containing 3′ neo.
Arrows indicate the positions of the STGC and LTGC
products. (D) Frequency of each gene conversion
event. Clones that were unable to be classified into ei-
ther STGC or LTGC are shown as “aberrant.”
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conversion (STGC) or long-tract gene conversion (LTGC)
is used (Johnson et al. 1999). To generate the STGC prod-
uct, only 300 base pairs (bp) of DNA synthesis is required.
In contrast, >3.3 kb of DNA synthesis is required to gener-
ate the LTGC product. A similar large product can be gen-
erated by sister chromatid exchange (SCE), but this is a
rare event (Johnson and Jasin 2000).
To analyze the putative role of MCM8–9 in DSB-
induced HR, we compared wild-type DT40 cells with
MCM8-KO orMCM9-KO. Initially, we looked at HR effi-
ciency by quantifying Neo-resistant clones following I-
SceI expression. This revealed that the MCM8-KO and
MCM9-KO cells showed comparably reduced HR effi-
ciencies, as reported previously (Fig. 6B; Lutzmann et al.
2012; Nishimura et al. 2012). Next, we analyzed the
Neo-resistant clones that did arise in the MCM8-KO
andMCM9-KO cells to define the outcome of the HR re-
actions. LTGC products can be distinguished from STGC
by the size of a SacI–KpnI restriction fragment (Fig. 6A).
In the wild-type background, 17% of clones were generat-
ed by LTGC, while this was reduced to 5% in the
MCM8-KO and MCM9-KO cells (Fig. 6C,D). Conversely,
STGC frequencies were elevated in the MCM8-KO and
MCM9-KO cells. Taken together, we conclude that the
MCM8–9 complex promotes DNA synthesis during
DSB-induced HR.
MCM8–9-dependent DNA synthesis is distinct from
RAD52-dependent MiDAS
Recently, it was shown thatDNA synthesis could occur at
common fragile sites in the human genome in the early
stages of mitosis if cells are exposed to replication stress
(Minocherhomji et al. 2015). This MiDAS requires
RAD52 and ismechanistically distinct from conventional
DNA replication (Bhowmick et al. 2016). Therefore,
we investigated whether MCM8–9 might function in Mi-
DAS. To this end, we disrupted theMCM8 gene in U2OS
cells, in which MiDAS is known to occur very efficiently
(Supplemental Fig. S7A–C; Minocherhomji et al. 2015).
We then treated MCM8-WT and MCM8-KO U2OS cells
with a low dose of the DNA polymerase inhibitor aphidi-
colin to induce replication stress and with the CDK1 in-
hibitor RO-3306 to induce a late G2-phase arrest. The
cells were then released into mitosis in the presence of
EdU to define sites of newDNAsynthesis occurring inmi-
tosis. Unexpectedly, we found that two independent
clones of MCM8-KO cells showed an increase in EdU in-
corporation compared with MCM8-WT cells, showing
that MiDAS is enhanced in MCM8-KO cells (Fig. 7A,B).
Consistent with there being no role for MCM8–9 in Mi-
DAS, the frequency of 53BP1 nuclear bodies in the follow-
ing G1 phase (a marker of failed MiDAS) was unchanged
in the MCM8-KO cells (Supplemental Fig. S7D,E; Mino-
cherhomji et al. 2015). Interestingly, a similar increase
in EdU incorporation has been observed previously in
RAD51-depleted cells (Bhowmick et al. 2016). Therefore,
we analyzed the epistatic relationship between RAD51
and MCM8–9. For this, we depleted RAD51 using siRNA
in MCM8-WT and MCM8-KO cells and then quantified
MiDAS (Fig. 7C; Supplemental Fig. S7F). We observed
that RAD51 depletion enhanced the level of MiDAS in
theMCM8-WT cells but not theMCM8-KO cells, consis-
tent with RAD51 and MCM8–9 operating in the same
pathway (Fig. 7C). We conclude that the RAD51/
MCM8–9 axis promotes a backup form of DNA synthesis
that is distinct from MiDAS.
Discussion
Inactivating MCM2–7 as a novel strategy for stalling
replication forks
Replication stress is frequently induced in cells by expo-
sure to aphidicolin or hydroxyurea. These agents can
Figure 7. The RAD51–MCM8–9 axis is not involved in MiDAS.
(A) MCM8-WT and MCM8-KO U2OS cells were treated with a
low dose of aphidicolin and RO-3306 before being released into
mitosis in the presence of EdU. Sites of EdU incorporation (Mi-
DAS) were visualized using the Click-iT reaction. Bars, 10 µm.
(B) Quantification of the number of EdU foci from A. (C ) Quanti-
fication of MiDAS in cells with or without RAD51 depletion. (D)
Schematic diagram outlining themultiple pathways that contrib-
ute to DNA synthesis and ensure the completion of genomic
DNA duplication before chromosome segregation (see the text
for details).
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lead toDSB formation, albeit after a long period of drug ex-
posure (Petermann et al. 2010; Toledo et al. 2013). Howev-
er, it is impossible to study DSB-induced DNA synthesis
using these inhibitors, as they inhibit polymerase func-
tion. An alternative approach is to use DNA-damaging
agents, but these cause the stalling of only a subset of rep-
lication forks, making it difficult to avoid fork conver-
gence (Supplemental Fig. S1). Therefore, an efficient
experimental system is required to permit the analysis
of protective mechanisms invoked in dealing with fork
stalling.
In prokaryotes, the response to fork stalling has been
studied either by using the replication terminator Ter or
through inactivation of the DnaB replicative helicase
(Horiuchi and Fujimura 1995; Seigneur et al. 2000). Simi-
larly, protein-mediated endogenous barriers have been
used for arresting replication forks in yeasts (Ahn et al.
2005; Calzada et al. 2005; Lambert et al. 2005). Recently,
the E. coliTus/Ter systemwas transplanted into yeast and
mouse cells to serve as a heterologous replication barrier
(Larsen et al. 2014; Willis et al. 2014). These studies re-
vealed detailed molecular events following fork pausing,
in which recombination proteins often played a promi-
nent part. Importantly, Willis et al. (2014) showed that
the HR induced following Tus-induced fork pausing was
regulated differently from that induced by a DSB.
Fork stalling caused by the inactivation of the replica-
tive MCM2–7 helicase has been achieved using the
heat-inducible degron system in budding yeast (Labib
et al. 2001). Analogous studies using the same experimen-
tal system have not been possible in human cells until
now because of the requirement for such a drastic temper-
ature shift to induce protein degradation. We have now
overcome this problem and achieved inactivation of
MCM2–7 at replication forks for the first time in human
cells by using AID technology (Nishimura et al. 2009;
Natsume et al. 2016). Although simultaneous stalling of
all forks is not expected to occur regularly under physio-
logical conditions (and therefore some cautionmust be ap-
plied to interpretation using the MCM2-mAID cells), we
suggest that this system could have broad applicability
in the study of fork stalling in the future. Consistent
with a previous report in yeast (Labib et al. 2001), we
showed that inactivation of MCM2–7 in human cells
causes fork stalling. Interestingly, this revealed the pres-
ence of residual DNA synthesis that occurred via an
MCM8–9-dependent process. This new DNA synthesis
was apparently not robust enough for the cells to com-
plete S phase, indicating that MCM8–9-dependent DNA
synthesis is either incapable of rescuing all stalled forks
or lacks the processivity to cover the full genome.Alterna-
tively, efficient fork restart might not be possible due to a
limitation in the cellular level of HR repair factors in cases
where multiple forks collapse simultaneously. MCM8–9-
dependent synthesis might be designed to operate less ef-
ficiently than conventional S-phase replication andmight
normally be called into action at only a very small number
of irreversibly stalled replication forks. Indeed, the
MCM8–9 system might represent a double-edged sword
for the maintenance of genome integrity. In support of
this idea, the expression level of MCM8–9 is >100 times
lower than that of MCM2–7 (Beck et al. 2011), and we
note that overexpression of MCM8–9 is detrimental to
proliferation (our unpublished data).
The MCM8–9 complex promotes HR-mediated DNA
synthesis
TheMCM8–9 complex has been implicated previously in
HR, although there is a lack of consensus concerning the
process involved (Nishimura et al. 2012; Park et al. 2013;
Lee et al. 2015). We demonstrated that the formation of
MCM8 foci is RAD51-dependent (Fig. 4B,C) and that
MCM8–9 is required for both DNA synthesis after fork
stalling induced by MCM2-mAID degradation (Fig. 5)
and DSB-induced HR (Fig. 6). These results are consistent
with previous observations showing that loss of the
MCM8 homolog in mice and flies affects meiotic recom-
bination only at a stage after the loading of the meiosis-
specific RAD51 homolog DMC1 (Blanton et al. 2005;
Lutzmann et al. 2012). Considering that the CMGholohe-
licase and theMCM8–9 complex each possess helicase ac-
tivity (Ilves et al. 2010; Traver et al. 2015), we propose that
MCM8–9 promotes DNA synthesis following RAD51-de-
pendent DNA strand invasion between sister chromatids
by acting as an alternative replicative helicase (Fig. 7D). In
the future, it will be interesting to test whether DNA syn-
thesis driven by MCM8–9 is semiconservative, like in
normal DNA replication, or conservative in nature. This
is because recent reports indicated that DNA synthesis
occurring during BIR in yeast and DNA synthesis occur-
ring during both the alternative lengthening of telomeres
process and MiDAS in human cells are conservative
events (Saini et al. 2013; Bhowmick et al. 2016; Roume-
lioti et al. 2016). It should be noted that, even though we
propose that MCM8–9 promotes DNA synthesis in HR,
it is possible that MCM8–9 is also involved in the resec-
tion of DSB ends (Lee et al. 2015). Both the human
HCT116 and the chicken DT40 cells that we studied are
recombination-proficient, and therefore any defect in re-
section might be masked by the availability of redundant
resection systems dependent on BLM, DNA2, or EXO1
(Gravel et al. 2008; Mimitou and Symington 2008; Zhu
et al. 2008).
HR involved in interstrand cross-link (ICL) repair
We reported previously that the MCM8–9 complex is in-
volved in HR-mediated ICL repair (Nishimura et al.
2012). Studies using Xenopus egg extracts showed that
ICL repair in a replication-competent plasmid proceeds
only after the convergence of replication forks on either
side of the ICL (Raschle et al. 2008; Zhang et al. 2015).
DSBs generated by ICL unhooking are repaired using
HR. Indeed, MCM8–9 has been detected at sites of ICLs
in the Xenopus system but was found not to be essential
for ICL repair (Park et al. 2013). On the other hand, cells
deficient inMCM8 orMCM9 are hypersensitive to ICL-in-
ducing anti-cancer agents but onlymarginally sensitive to
ionizing radiation, which generates two-ended DSBs
Natsume et al.
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(Nishimura et al. 2012; Park et al. 2013). We hypothesize
that most ICLs are repaired through a two-ended DSB
intermediately following fork convergence at the ICL.
However, a small number of ICLs are converted into
one-ended DSBs, the repair of which requires extensive
DNA synthesis using MCM8–9. If true, this model might
be particularly relevant to the repair of one-ended DSBs
induced by ICLs that arise at chromosome fragile sites,
where a single fork might have to travel over a long
distance.
Noncanonical DNA syntheses as a backup of DNA
replication
We showed that the RAD51/MCM8–9 axis operates
separately from MiDAS. We therefore propose that cells
have at least three systems to deal with instances of fork
stalling (Fig. 7D): fork convergence, MCM8–9-dependent
DNA synthesis, and MiDAS. We hypothesize that
MCM8–9-dependent DNA synthesis and MiDAS are
mechanistically related by being functionally analogous
to yeast BIR but use a different set of HR factors.
Archaeal replicationwas carried out by anMCMhomo-
hexameric helicase. It is likely that the archaeal MCM
helicase can carry out both origin-dependent and HR-me-
diated DNA replication (Hawkins et al. 2013). We specu-
late that, in eukaryotes, the MCM2–7 and MCM8–9
helicases evolved from a single ancestral MCM in order
to catalyze origin-dependent DNA replication and HR-
mediated DNA synthesis, respectively. This division of
labor might have occurred in response to the establish-
ment of the replication licensing system in eukaryotes
(Blow and Dutta 2005). Evolutional loss of the MCM8
and MCM9 genes in yeast might be due to the fact that
the number and distribution of origins on chromosomes
evolved for optimal fork convergence so that MCM8–9-
dependent DNA synthesis was dispensable in the ances-
tor of yeast (Liu et al. 2009; Newman et al. 2013). Further
analysis of the fate of stalled forks and the role of MCM8–
9 in their repair will hopefully reveal the relationship be-
tween conventional DNA replication and HR-mediated
DNA synthesis in human cells.
Materials and methods
Cell lines
Genetically engineeredHCT116 cell lines used in this studywere
as follows: HCT116MCM2-mAID (clone 1: #269; clone 2: #270),
HCT116 MCM2-mAID AtAFB2 (#310), HCT116 MCM2-mAID
AtAFB2 MCM8–mCherry2 (#353), and HCT116 MCM2-mAID
AtAFB2 MCM8–mCherry2 MCM9-KO (clone 1: #395; clone 2:
#396; clone 3: #398). Genetically engineered U2OS cell lines
used in this study were as follows: U2OS MCM8-KO (clone 1:
#513; clone 2: #514).
Cell culture, transfection, and cloning
Human cell culturewas undertaken as described previously (Nat-
sume et al. 2016). To induce the degradation of MCM2-mAID,
500 µM indole-3-acetic acid (IAA; a natural auxin; Nacalai Tes-
que) was added to the culture medium unless otherwise noted.
The RAD51 inhibitor RI-1 (Abcam) and bleomycin (Nippon
Kayaku) were used at concentrations of 100 µM and 10 µg/mL, re-
spectively. Transfection was performed using FuGENE HD
(Promega). Transfected cells were selectedwith 1 µg/mL puromy-
cin, 700 µg/mL G418, or 100 µg/mL HygroGold (InvivoGen). The
detailed procedure for generation of mutant cells was described
previously (Natsume et al. 2016).
Cell synchronization
HCT116 cells were synchronized in the G1 phase as described
previously (Javanmoghadam-Kamrani and Keyomarsi 2008).
Briefly, asynchronously growing HCT116 cells were treated
with 20 µM lovastatin (LKT Laboratories) for 24 h to arrest
them in G1 phase. Following that, the cells were washed twice
with fresh medium and then grown in medium containing 2
mM mevalonic acid (Sigma-Aldrich).
RNAi
For depletion of the MCM2 and MCM5 proteins, HCT116 cells
were transfected with 50 nM Silencer Select siRNAs (Thermo
Fisher Scientific) using Lipofectamine RNAiMAX reagent
(Thermo Fisher Scientific) following the manufacturer’s instruc-
tions. The transfected cells were harvested after 72 h. RAD51
depletion in U2OS cells was performed as described previously
(Bhowmick et al. 2016). We used the following siRNAs: siCONT
(negative control; 4390843), MCM2-1 (s8586), MCM2-2 (s8587),
MCM2-3 (s8588), MCM5-1 (s8595), and Mcm5-1i and Mcm5-2i
(Ge et al. 2007).
Plasmid construction
We used pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene,
42230) for the construction of CRISPR plasmids following a pub-
lished protocol (Ran et al. 2013). To construct a donor plasmid for
the expression of A. thalianaAFB2 (AtAFB2) from the AAVS1 lo-
cus, pMK232wasmodified (Natsume et al. 2016). The donor plas-
mid for tagging MCM2 with mAID was constructed by using
PCR-amplified homology arms (1 kb each) and pMK286. The
donor plasmid for tagging MCM8 with mCherry2 was construct-
ed by using PCR-amplified homology arms (850 bp each) and
pMK281. The donor plasmid for generating MCM8-KO in a
U2OS background was constructed by using PCR-amplified ho-
mology arms (900 bp each) and a puromycin-resistant gene from
pMK194.
Genomic PCR
To prepare genomic DNA, cells were lysed in buffer (100 mM
Tris-HCl at pH 8.0, 200 mM NaCl, 5 mM EDTA, 1% SDS, and
0.6mg/mL proteinase K) for 1 h at 55°C. After isopropanol precip-
itation, DNA pellets were washed with 70% ethanol and resus-
pended in TE containing 50 µg/mL RNase A overnight at 37°C.
Genomic PCR was performed using Tks Gflex DNA polymerase
(Takara Bio) according to the manufacturer’s instructions (30 cy-
cles of the following protocol: 10 sec at 98°C, 15 sec at 55°C, and
0.5 min at 68°C per kilobase).
Flow cytometry
Cells were collected and fixed in 70% ethanol. Fixed cells were
washed once with PBS and then resuspended in PBS containing
1% BSA, 50 µg/mL RNase A, and 40 µg/mL propidium iodide.
MCM8–9 promotes DNA synthesis after fork stalling
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After incubation for 30min at 37°C, the cells were filtered though
a nylon mesh filter (42-µm pore size). DNA content was mea-
sured using anAccuri C6 flow cytometer (BDBiosciences) and an-
alyzed by FCS Express 4 software (De Novo Software). For the
analysis of DNA synthesis, cells were pulse-labeled with 30 µM
BrdU before fixation with 90% ethanol. After washing with
PBS, the fixed cells were treated with 2 M HCl and 0.5% Triton
X-100 for 30 min for denaturing of genomic DNA. The cells
were gently resuspended in 0.1MNa2B4O7 (pH8.5) and incubated
for 30 min. After washing once with the antibody solution (1%
BSA, 0.2% Tween 20 in PBS), cells were treated with the anti-
BrdU antibody (BD Biosciences, B44) diluted in the antibody sol-
ution for 30 min. After washing once, the cells were treated with
the FITC-conjugated anti-mouse antibody (Jackson Laboratory)
diluted in the antibody solution for 30 min. Finally, the cells
were treated with the antibody solution containing 50 µg/mL
RNase A and 40 µg/mL propidium iodide before flow cytometer
analysis.
Immunofluorescence staining
HCT116 cells were cultured in a glass-bottomed dish (MatTek)
before fixation with 3.7% formaldehyde/PBS for 15 min. After
washing twice with PBS, the cells were permeabilized with
0.5% Triton X-100/PBS for 20 min followed by a blocking treat-
ment with 3% skim milk/PBS for 1 h. After washing twice with
PBS, primary antibodies diluted in 1% BSA/PBS were applied be-
fore incubation for 1 h at room temperature. After washing three
times with 0.05% Tween 20/PBS (PBS-T), secondary antibodies
diluted in 1% BSA/PBS were applied before incubation for 1 h
at room temperature. The cells were washed twice with PBS-T
and once with PBS before DNA staining with 5 µg/mL Hoechst
33342 in PBS for 30 min. The coverslips were overlaid with Vec-
taShield mounting medium (Vector Laboratories). Incorporated
EdU was visualized using Click-iT Plus Alexa fluor 647 imaging
kit (Thermo Fisher Scientific) before primary antibody treatment
following the manufacturer’s instruction.
Protein detection
To preparewhole-cell extracts, cells were lysed in RIPA buffer (25
mM Tris-HCl at pH 7.6, 150 mM NaCl, 1% Nonidet P-40, 1%
sodium deoxycholate, 0.1% SDS) containing a protease inhibitor
cocktail (Complete EDTA-free, Roche). Protein concentration
was then measured using a Bradford assay kit (Bio-Rad). Tris-
SDS (2×) sample buffer (125 mM Tris-HCl at pH 6.8, 4% SDS,
20% glycerol, 0.01% bromophenol blue, 10% 2-mercaptoetha-
nol) was then added, and the samples were incubated for 5 min
at 95°C. Preparation of chromatin-bound proteins was performed
as described previously (Nishitani et al. 2014). Proteins were sep-
arated using SDS-PAGE, transferred to a nitrocellulose mem-
brane (Protran Premium NC 0.45, GE Healthcare Life Sciences),
and then incubated with antibodies after blocking with 5%
skim milk/TBS-T for 30 min at room temperature. Detection
was performed using ECL Prime detection reagent (GE Health-
care Life Sciences) with a ChemiDoc touch imaging system
(Bio-Rad).
Antibodies
Antibodies used for immunoblotting and immunofluorescence
were as follows: anti-MCM8 and anti-MCM9 antibodies (raised
in rabbits; in-house antibodies), anti-MCM2 antibody (Santa
Cruz Biotechnology, sc-9839), anti-MCM5 antibody (Santa Cruz
Biotechnology, sc-22780), anti-mAID antibody (MBL, M214-3),
anti-RFPantibody (MBL,M204-3), anti-RAD51 antibody (BioAca-
demia, 70001), anti-γH2AX antibody (Millipore, 05-636), anti-
53BP1 antibody (Santa Cruz Biotechnology, sc-22760), anti-His-
toneH3 (Abcam, ab1791; andActiveMotif, 39763), anti-α-tubulin
(Sigma, 00020911), and anti-phospho-CHK1 (Ser345) antibody
(Cell Signaling, 2341). For detection of MCM8-mCherry2, RFP-
Booster ATTO 594 (Chromotek, rba594) was used.
Microscopy
Cells were visualized using a DeltaVision microscope equipped
with deconvolution software, an incubation chamber, and a
CO2 supply (GE Healthcare Life Sciences). For live-cell imaging,
HCT116 cells were cultured in a glass-bottomed dish (MatTek)
at 37°C with 5% CO2. To visualize nuclei in live cells, 10 µg/
mL Hoechst 33342 was added to the medium before observation.
DNA damage foci were analyzed using the Volocity software
(PerkinElmer).
PFGE
PFGE was performed using a published protocol (Zellweger et al.
2015). To prepare cell plugs, 2 × 105 cells were embedded in 1% 2-
hydroxyethylagarose (Sigma-Aldrich) using the 50-well plug
mold (Bio-Rad). To lyse cells, the cell plugs were incubated in
the plug lysis buffer (100 mM EDTA at pH 8.0, 1% sarkosyl,
0.2% sodium deoxycholate, 1 mg/mL proteinase K) overnight at
37°C. The cell plugs were washed once with the plug wash buffer
(20 mM Tris-HCl at pH 8.0, 50 mM EDTA) before insertion into
the wells of a 0.9% agarose gel. PFGE was performed using a
CHEF Mapper XA PFGE system (Bio-Rad) with 0.5× TBE for 21
h at 14°C as follows: block 1: 9 h, 120° pulse angle, 5.5 V/cm,
30 sec to 18 sec switch time; block 2: 6 h, 117° pulse angle, 4.5
V/cm, 18 sec to 9 sec switch time; and block 3: 6 h, 112° pulse an-
gle, 4.0 V/cm, 9 sec to 5 sec switch time. The gel was stainedwith
GelGed (Biotium), and images were acquired using a ChemiDoc
touch imaging system (Bio-Rad) and analyzed using Image Lab
software (Bio-Rad).
DNA fiber assays
DNA fiber assays were performed following a published protocol
with minor modifications (Schwab and Niedzwiedz 2011). Cells
were pulse-labeled with 25 µM IdU for 30 min followed by a sec-
ond labelingwith 250 µMCldU for 30min. The labeled cells were
collected in ice-cold medium. Twomicroliters of cell suspension
was spotted onto the Aminosilane-coated glass slide (Matsu-
nami). Seven microliters of the fiber lysis solution (200 mM
Tris-HCl at pH 7.5, 50 mM EDTA, 0.5% SDS) was applied onto
the cells, followed by a gentle stirring. After 5 min, the glass slide
was tilted at an angle of 15°, allowing DNA fibers to spread. After
air-drying, the slide was treated with methanol/acetic acid (3:1)
for 10 min to fix DNA fibers and then with 2.5 M HCl for 80
min to denature DNA. After washing three times with PBS, the
slide was treated with PBS containing 5% BSA for 30 min for
blocking. The slide was treated with antibodies (mouse B44 [BD
Biosciences] and rat BU1/75 [Abcam] for IdU and CldU, respec-
tively) for 1 h at room temperature. After washing three times
with PBS, the slide was treated with Alexa fluor 594-conjugated
anti-mouse IgG antibodies (Thermo Fisher Scientific, A-11032)
and Alexa fluor 488 anti-rat IgG antibodies (Thermo Fisher Scien-
tific, A-11006) for 1 h at room temperature. After three washes
with PBS, the slide was sealed with a coverslip using VectaShield
mounting medium (Vector Laboratories). Images were captured
using an Olympus BX51 microscope with a DP72 CCD camera.
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I-SceI-induced gene conversion assay
The I-SceI-induced gene conversion assay was performed as de-
scribed previously (Yamamoto et al. 2005).
Detection of MiDAS
The assay was performed as described previously with minor
modifications (Minocherhomji et al. 2015). Briefly, the assay
used Click-iT chemistry according to themanufacturer’s instruc-
tions but with a 1× final concentration of the Click-iT EdU buffer
additive (Click-iT EdUAlexa fluor 594 imaging kit, Thermo Fish-
er Scientific). Asynchronously growing cells were treated with
low-dose APH (0.4 µM) and RO-3306 (9 µM) (Sigma) for 16
h. Cells synchronized in lateG2were released into early prophase
by vigorouswashing (three to four times for up to 5min eachwith
1× PBS prewarmed to 37°C). Subsequently, cells in early prophase
were maintained for 30 min at 37°C in a humidified atmosphere
containing 5% CO2 in prewarmed fresh medium supplemented
with10 µM EdU (Thermo Fisher Scientific). Loosely attached mi-
totic cells were then shaken off and seeded on polylysine-coated
slides and kept for 10 min at room temperature before simultane-
ous fixation and permeabilization using PTEMF buffer and subse-
quent EdU detection using Click-iT chemistry.
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